Concepedia

Perla Breccia

PB

Statistics

Publications

12

Citations

592

H-Index

11

Active since

2002

Affiliations

CHDI Foundation(Current)

Charles River Laboratories (United Kingdom)

Universidad Autónoma de Madrid

University of Rome Tor Vergata

Charles River Laboratories (Netherlands)

Perla Breccia is an author at CHDI Foundation specializing in enzyme inhibition, medicinal chemistry, and pharmacology.

ORCID

Publications per year

2002–2022

12

Publications

12

Design, Synthesis, and Biological Evaluation of Potent and Selective Class IIa Histone Deacetylase (HDAC) Inhibitors as a Potential Therapy for Huntington’s Disease

Roland W. Bürli, Christopher A. Luckhurst, Omar Aziz et al. · Journal of Medicinal Chemistry · 2013 · 149 citations · Full text

, , +13

Guanidinium Receptors as Enantioselective Amino Acid Membrane Carriers

Perla Breccia, Michiel Van Gool, Ruth Pérez‐Fernández et al. · Journal of the American Chemical Society · 2003 · 116 citations

, , +15

Enantioselective Transport by a Steroidal Guanidinium Receptor

Beatriz Baragaña, Adrian G. Blackburn, Perla Breccia et al. · Chemistry - A European Journal · 2002 · 62 citations · Full text

, , +9

Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors

Christopher A. Luckhurst, Perla Breccia, Andrew J. Stott et al. · ACS Medicinal Chemistry Letters · 2015 · 55 citations · Full text

, , +10

Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor

Christopher A. Luckhurst, Omar Aziz, Vahri Beaumont et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 46 citations

, , +9

1–5 of 12